Modulation of monocyte subsets in infectious diseases

被引:0
|
作者
Mignane B Ka [1 ,2 ]
Daniel Olive [1 ]
Jean-Louis Mege [2 ]
机构
[1] Inserm Unité Mixte de Recherche(UMR) 1068,Centre de Recherche en Cancérologie de Marseille,13009 Marseille,France
[2] Department of Immunology and Infectious Diseases,Aix Marseille University,URMITE,UM63,CNRS 7278,IRD 198,INSERM 1095,13005 Marseille,France
关键词
Monocytes subsets; Infection; Virus; Bacteria;
D O I
暂无
中图分类号
R63 [外科感染];
学科分类号
1002 ; 100210 ;
摘要
Monocytes are effector immune cells but a precise analysis of their role in immune response has been precluded by their heterogeneity. Indeed,human monocytes are composed of at least three different subsets with different phenotypic characteristics and functional properties,the so-called classical,intermediate and nonclassical monocytes. A review of the literature shows that these monocyte subsets are differently affected during viral,bacterial,parasitic and fungal infections.The expansion of the CD16+ compartment(intermediate and non-classical monocytes) is typically observed in the majority of infectious diseases and the increased proportion of CD16+ monocytes is likely related to their activation through their direct interaction with the pathogen or the inflammatory context. In contrast,the number of non-classical and intermediate monocytes is decreased in Q fever endocarditis,suggesting that complex mechanisms govern the equilibrium among monocyte subsets. The measurement of monocyte subsets would be useful in better understanding of the role of monocyte activation in the pathophysiology of infectious diseases.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 50 条
  • [1] The Role of Glycosylation in Infectious Diseases
    Zhang, Xiao-Lian
    Qu, Haoran
    ROLE OF GLYCOSYLATION IN HEALTH AND DISEASE, 2021, 1325 : 219 - 237
  • [2] Role of infectious diseases in human carcinogenesis
    Herrera, LA
    Benítez-Bribiesca, L
    Mohar, A
    Ostrosky-Wegman, P
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2005, 45 (2-3) : 284 - 303
  • [3] Platelets as immune cells in infectious diseases
    Speth, Cornelia
    Loeffler, Juergen
    Krappmann, Sven
    Lass-Floerl, Cornelia
    Rambach, Guenter
    FUTURE MICROBIOLOGY, 2013, 8 (11) : 1431 - 1451
  • [4] Resolution pharmacology and the treatment of infectious diseases
    Costa, Vivian Vasconcelos
    Resende, Filipe
    Melo, Eliza Mathias
    Teixeira, Mauro Martins
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (07) : 917 - 937
  • [5] Update on infectious enterocolitides and the diseases that they mimic
    Lamps, Laura W.
    HISTOPATHOLOGY, 2015, 66 (01) : 3 - 14
  • [6] Update on rheumatic manifestations of infectious diseases
    Becker, Jennifer
    Winthrop, Kevin L.
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (01) : 72 - 77
  • [7] Climate and infectious diseases
    Kelly-Hope, Louise
    Thomson, Madeleine C.
    SEASONAL FORECASTS, CLIMATIC CHANGE AND HUMAN HEALTH: HEALTH AND CLIMATE, 2008, 30 : 31 - +
  • [8] Ficolins and infectious diseases
    Yushan Ren
    Quanquan Ding
    Xiaolian Zhang
    Virologica Sinica, 2014, (01) : 25 - 32
  • [9] Breastfeeding With Infectious Diseases
    Yeo, Samantha
    Yang, Liying
    Ong, Kirsten
    Yong, Tze Tein
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2022, 31
  • [10] Infectious diseases affecting the small bowel - what not to miss
    Keuchel, Martin
    Bota, Marc
    Baltes, Peter
    CURRENT OPINION IN GASTROENTEROLOGY, 2021, 37 (03) : 255 - 266